Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMEL1 | Q495T6 | 3/20 | 0.48 |
| ▸ | MME | P08473 | 5/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | PPID | Q08752 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13744623 | 0.90 | MME (0.54) | MMEL1MMEHPGDABCB1 | |
| SCHEMBL2636079 | 0.84 | ALDH1A1 (0.51) | MMEL1MMEMMP8TP53HPGD | |
| SCHEMBL13825642 | 0.83 | ALDH1A1 (0.52) | MMEHPGD | |
| SCHEMBL13744224 | 0.82 | MME (0.48) | MMEL1MME | |
| SCHEMBL13825640 | 0.81 | MME (0.50) | MMEL1MMEHPGD | |
| SCHEMBL14959388 | 0.81 | MMEL1 (0.59) | MMEL1MME | |
| SCHEMBL14611003 | 0.80 | CTRB1 (0.53) | ABCB1 | |
| SCHEMBL14392786 | 0.80 | CTRB1 (0.53) | ABCB1 | |
| SCHEMBL6222640 | 0.80 | MMEL1 (0.45) | MMEL1PPID | |
| SCHEMBL8141223 | 0.78 | ALDH1A1 (0.53) | MMP8TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203694-A1 | INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE | HURLEY TIMOTHY BRIAN | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203694-A1 | INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE | FDPS, UMPS, GGPS1 | MMEL1 1247/4885MME 1183/4885MMP8 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.